Sue Foxall
About Sue Foxall
Sue Foxall is a Senior Scientist at BenevolentAI with over 25 years of experience in the pharmaceuticals industry, specializing in Molecular Biology and Drug Development.
Current Position at BenevolentAI
Sue Foxall serves as a Senior Scientist at BenevolentAI. She has been with the company since March 2018, applying her extensive expertise in Molecular Biology and Drug Development. BenevolentAI is known for its innovative use of artificial intelligence in drug discovery and development, and Foxall contributes significantly to these cutting-edge projects.
Career at Proximagen Limited
Sue Foxall worked at Proximagen Limited for a total of 9 years. She began her tenure as a Scientist in 2009 and later advanced to the role of Senior Scientist, a position she held from 2016 to 2018. During her time at Proximagen Limited, Foxall honed her skills in pharmaceuticals and biotechnology, contributing to various drug development projects.
Industry Experience in Biotechnology
Sue Foxall has over 25 years of experience in the pharmaceuticals and biotechnology industries. She has held various scientific roles at prominent companies such as Cambridge Biotechnology Ltd, Biovitrum - Cambridge Biotechnology, Monsanto, and Unilever. Her diverse experience includes specializing in Molecular Biology and contributing to significant advancements in drug development and biotechnology.
Educational Background
Sue Foxall completed her Bachelor of Applied Science (BASc) degree in Applied Biology from The Manchester Metropolitan University, graduating in 1996. She then pursued her Master of Philosophy (MPhil) from Wye College, University of London, which she completed in 1998. Her strong educational foundation has greatly contributed to her successful career in science and biotechnology.
Professional Background in Cambridge, UK
Sue Foxall has a longstanding history of working in Cambridge, UK. She has held scientific roles at several companies in the region including Biovitrum - Cambridge Biotechnology, Cambridge Biotechnology Ltd, Monsanto, and Unilever. Her work in these positions has enhanced her expertise in various aspects of biotechnology and pharmaceuticals, making her a valued professional in the industry.